Table 3.
Variable | OR (95% CI) | p-valuea) |
---|---|---|
CEA < 4.4 ng/dL | 6.71 (1.22-36.97) | 0.03 |
Sustained lymphocyte ratio ≥ 0.35 | 8.33 (1.54-45.12) | 0.02 |
Clinical N stage | 0.22 (0.02-2.57) | 0.22 |
OR, odds ratio; CI, confidence interval; CEA, carcinoembryonic antigen.
Logistic regression with backward stepwise method was performed.